(3-Chloro-5-(piperidine-1-carbonyl)phenyl)boronic acid, 95.0%, 1g

Plan PLPHi 10x/0.25 phase contrast IOS infinity corrected objective

(4R,4'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 250mg

3,5-Bis(trifluoromethyl)benzoic acid hydrazide, 97.0%, 100g

3,6-Dioctyloxyphthalonitrile, 97%, 1g

1,2,4,5-Tetramethyl-1H-imidazole, 95%, 1g

6-Methoxy-2-(trifluoromethyl)-1H-benzo[d]imidazole, 95.0%, 1g

Benzyl 4-(piperidin-4-yl)piperazine-1-carboxylate, 1g

TRIS[(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHYL]AMINE, 96%, 250mg

TERT-BUTYL 4-METHYL-3,5-DIOXO-2-AZABICYCLO[2.2.2]OCTANE-2-CARBOXYLATE, 90.0%, 5g

N-[4-(methylthio)benzyl]-2-propen-1-amine hydrochloride, 95.0%, 1g

V3XK jacket Size XL

4-(2-Phenyl-thiazol-4-yl)-phenylamine, 95.0%, 250mg